Phase I study of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic cancer

被引：0
|
作者：
Suguru Yamada
Tsutomu Fujii
Yukihiro Yokoyama
Hiroki Kawashima
Osamu Maeda
Kojiro Suzuki
Tohru Okada
Eizaburo Ono
Junpei Yamaguchi
Nao Takano
Hideki Takami
Masamichi Hayashi
Yukiko Niwa
Yoshiki Hirooka
Yoshiyuki Ito
Shinji Naganawa
Yuichi Ando
Masato Nagino
Hidemi Goto
Yasuhiro Kodera
机构：
[1] Nagoya University Graduate School of Medicine,Department of Gastroenterological Surgery (Surgery II)
[2] University of Toyama,Department of Surgery and Science, Graduate School of Medicine and Pharmaceutical Sciences
[3] Nagoya University Graduate School of Medicine,Division of Surgical Oncology, Department of Surgery
[4] Nagoya University Graduate School of Medicine,Department of Gastroenterology and Hepatology
[5] Nagoya University Hospital,Department of Clinical Oncology and Chemotherapy
[6] Aichi Medical University,Department of Radiology
[7] Nagoya University Graduate School of Medicine,Department of Radiology
[8] Nagoya University Hospital,Department of Endoscopy
来源：
Cancer Chemotherapy and Pharmacology | 2018年 / 81卷
关键词：
Phase I study; Gemcitabine; Nab-paclitaxel; Radiation; Unresectable locally advanced pancreatic cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：815 / 821
页数：6
相关论文
共 50 条
  • [1] Phase I study of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic cancer
    Yamada, Suguru
    Fujii, Tsutomu
    Yokoyama, Yukihiro
    Kawashima, Hiroki
    Maeda, Osamu
    Suzuki, Kojiro
    Okada, Tohru
    Ono, Eizaburo
    Yamaguchi, Junpei
    Takano, Nao
    Takami, Hideki
    Hayashi, Masamichi
    Niwa, Yukiko
    Hirooka, Yoshiki
    Ito, Yoshiyuki
    Naganawa, Shinji
    Ando, Yuichi
    Nagino, Masato
    Goto, Hidemi
    Kodera, Yasuhiro
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 81 (05) : 815 - 821
  • [2] Phase I study of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic cancer.
    Yamada, Suguru
    Fujii, Tsutomu
    Takano, Nao
    Takami, Hideki
    Suenaga, Masaya
    Niwa, Yukiko
    Hayashi, Masamichi
    Iwata, Naoki
    Kanda, Mitsuro
    Kobayashi, Daisuke
    Tanaka, Chie
    Nakayama, Goro
    Sugimoto, Hiroyuki
    Koike, Masahiko
    Fujiwara, Michitaka
    Kodera, Yasuhiro
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [3] The phase I study of concurrent chemoradiotherapy using a combination of gemcitabine and nab-paclitaxel for unresectable locally advanced pancreatic cancer: Update.
    Ioka, Tatsuya
    Katayama, Kazuhiro
    Takada, Ryoji
    Ohkawa, Kazuyoshi
    Takahashi, Hidenori
    Teshima, Teruki
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [4] The Survival Benefit of Chemoradiotherapy following Induction Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Unresectable Locally Advanced Pancreatic Cancer
    Takada, Ryoji
    Ikezawa, Kenji
    Daiku, Kazuma
    Maeda, Shingo
    Abe, Yutaro
    Urabe, Makiko
    Kai, Yugo
    Yamai, Takuo
    Fukutake, Nobuyasu
    Nakabori, Tasuku
    Uehara, Hiroyuki
    Ashida, Reiko
    Akita, Hirofumi
    Takahashi, Hidenori
    Teshima, Teruki
    Ohkawa, Kazuyoshi
    CANCERS, 2021, 13 (18)
  • [5] EFFICACY OF GEMCITABINE/NAB-PACLITAXEL INDUCTION CHEMOTHERAPY FOLLOWED BY CHEMORADIOTHERAPY FOR UNRESECTABLE LOCALLY ADVANCED PANCREATIC CANCER
    Takada, Ryoji
    Ikezawa, Kenji
    Kiyota, Ryosuke
    Imai, Toshihiro
    Yutaro, Abe
    Fukutake, Nobuyasu
    Takatoshi, Nawa
    Katayama, Kazuhiro
    Ohkawa, Kazuyoshi
    GASTROENTEROLOGY, 2020, 158 (06) : S865 - S866
  • [6] Conversion surgery with gemcitabine plus nab-paclitaxel for locally advanced unresectable pancreatic cancer: A case report
    Okura, Ryosuke
    Takano, Shigetsugu
    Yokota, Tetsuo
    Yoshitomi, Hideyuki
    Kagawa, Shingo
    Furukawa, Katsunori
    Takayashiki, Tsukasa
    Kuboki, Satoshi
    Suzuki, Daisuke
    Sakai, Nozomu
    Nojima, Hiroyuki
    Mishima, Takashi
    Miyazaki, Masaru
    Ohtsuka, Masayuki
    MOLECULAR AND CLINICAL ONCOLOGY, 2018, 9 (04) : 389 - 393
  • [7] Gemcitabine plus Nab-Paclitaxel with chemoradiation in locally advanced pancreatic cancer (LAPC)
    Olowokure, Olugbenga
    Torregroza-Sanchez, Maria Patricia
    Bedoya-Apraez, Ivan Dario
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2013, 4 (02) : E16 - E18
  • [8] Gemcitabine plus nab-paclitaxel for locally advanced or borderline resectable pancreatic cancer
    Tsujimoto, Akiko
    Sudo, Kentaro
    Nakamura, Kazuyoshi
    Kita, Emiri
    Hara, Ryusuke
    Takayama, Wataru
    Ishii, Hiroshi
    Yamaguchi, Taketo
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [9] Gemcitabine plus nab-paclitaxel for locally advanced or borderline resectable pancreatic cancer
    Akiko Tsujimoto
    Kentaro Sudo
    Kazuyoshi Nakamura
    Emiri Kita
    Ryusuke Hara
    Wataru Takayama
    Hiroshi Ishii
    Taketo Yamaguchi
    Scientific Reports, 9
  • [10] Gemcitabine Plus Nab-Paclitaxel Versus FOLFIRINOX in Locally Advanced, Unresectable Pancreatic Cancer A Multicenter Observational Study (NAPOLEON Study)
    Arima, Shiho
    Kawahira, Machiko
    Shimokawa, Mototsugu
    Ido, Akio
    Koga, Futa
    Ueda, Yujiro
    Nakazawa, Junichi
    Komori, Azusa
    Otsu, Satoshi
    Fukahori, Masaru
    Makiyama, Akitaka
    Taguchi, Hiroki
    Honda, Takuya
    Shibuki, Taro
    Mitsugi, Kenji
    Nio, Kenta
    Ide, Yasushi
    Ureshino, Norio
    Mizuta, Toshihiko
    Shirakawa, Tsuyoshi
    Otsuka, Taiga
    PANCREAS, 2021, 50 (07) : 957 - 964
12345